Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Burkitt Lymphoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Recurrence 2Neoplasm, Residual 2Leukemia, Biphenotypic, Acute 2Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myeloid 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Large Granular Lymphocytic 1Leukemia 1Hodgkin Disease 1Hematologic Neoplasms 1Down Syndrome 1Blast Crisis 1

Interventions

Cyclophosphamide 9fludarabine 5zanubrutinib 3Vincristine 3Rituximab 3Doxorubicin 3pirtobrutinib 2cemiplimab 2Specimen Handling 2Prednisone 2Magnetic Resonance Spectroscopy 2Leukapheresis 2Immunotherapy, Adoptive 2Etoposide 2Dexamethasone 2Cell- and Tissue-Based Therapy 2tafasitamab 1sodium-iodide symporter 1selinexor 1ruxolitinib 1pomalidomide 1polatuzumab vedotin 1obinutuzumab 1ibrutinib 1glofitamab 1etoposide phosphate 1blinatumomab 1acalabrutinib 1X-Rays 1Surveys and Questionnaires 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, B-Cell × blinatumomab × 30 days × Clear all
NCT03114865 2026-06-03

A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Active not recruiting
44 enrolled
LymphoidOther hematologic neoplasm

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡